Table 1

Baseline and follow-up data of the eyes

BaselineLong-term follow-up
General information
 Number of eyes18
 Sex11 females, 7 males
 Age31 (range: 23–56) years
 Aetiology15 SJSs, 3 GVHDs
 Medical history6 (range: 0.7–33) years
Data of grafts
 Donor sites12 low lips,
5 upper lips,
1 buccal mucosa
 Sizes8.1 (range: 5.8–15) cm2
 MSGFR1.7 (range: 0.9–3.3) µL/min/cm2
Patients questionnaire
 Follow-up time6 (range: 4–8) years
 Number of eyes18
 Relief of DED symptoms58.8%*
 Satisfaction rate70.6%*
Ophthalmological evaluations
 Follow-up time3.5 (range: 2–8) years
 Number of eyes17†
 Schirmer test0 (IQR: 0–0.5) mm4 (IQR: 1–7) mm‡
 FL12 (IQR: 10–12)10 (IQR: 8–12)‡
 TBUT0 s0 s in 15 eyes,
2 s in two eyes
 BCVA0.05 (IQR: 0.01–0.1)0.05 (IQR: 0.02–0.33)
  • *Only the right eye was included in the patient undergoing bilateral surgeries.

  • †The ophthalmological examinations of the eye lost to follow-up after 3 months were not included in the analysis.

  • ‡P §amp;lt; 0.05.

  • BCVA, best-corrected visual acuity; DED, dry eye disease; FL, corneal fluorescein staining score; GVHD, graft versus host disease; MSGFR, salivary flow rate of minor salivary glands; SJS, Stevens-Johnson syndrome; TBUT, value of break-up time of tear-film.